Working with researchers at the Mayo Clinic, Illinois Bioengineering Assistant Professor Gregory Underhill have developed an engineering-based tool that helps unravel the extracellular matrix' (ECMs) composition and underlying mechanisms that enable cancer to spread and become resistant to chemotherapy and other treatments.
